chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She got her vaccine that was mixed in with the COVID/RSV cnotinued.  Her sister came home and found her on the floor by the bathroom.  Went downhill from there.  By Sunday she was not able to walk and they had to get her in the truck and she could not get back into the truck by herself.  At that point she had so much fluid she was at 180# or so and she normally weighs 144.  They took her to hospital and then it was another hospital.  In the ER they tried to rehabilitate her.  They gave her medicine to get rid of the fluid, did rehab to get her to walk again.  It took 2 people to lift her when she got to hospital, and she wobbles some now but she is doing a lot better.  She went to one hospital and went home, was in such bad shape again and was admitted to the other hospital.  They never did her a diagnosis of what was wrong in either of the hospitals.  She is able to walk now but wobbly.  She is improving daily.  She is able to get her mail, walk to get it.  The fluid has stayed under control now.  The medicine in the hospital was fluid that she had accumulated.  She is smaller now than she was when she went into the hosiptal.  She apparently retaining fluid and didn't know it as her clothes are now large.
atrial fibrillation; I suffered 2 small ischemic strokes; blood clots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 76-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Mar2022 at 17:00 as dose 4 (booster), single (Lot number: FK9095) at the age of 76 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: sulfa drugs" (unspecified if ongoing), notes: known allergies: sulfa drugs; "macular degeneration" (unspecified if ongoing); "PSVBs" (unspecified if ongoing), notes: PSVBs; "osteoporosis" (unspecified if ongoing); "osteoarthritis" (unspecified if ongoing); "IBS" (unspecified if ongoing). Concomitant medication(s) included: ACEBUTOLOL; TELMISARTAN; SYNTHROID; ALLEGRA; ALIGN. Vaccination history included: BNT162b2 (Dose Number: 3, Batch/Lot No: FG3527, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM), administration date: 01Nov2021, when the patient was 76-year-old, for Covid-19 Immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: EL8982, Location of injection: Arm Left, Vaccine Administration Time: 10:00 AM), administration date: 06Feb2021, when the patient was 75-year-old, for Covid-19 Immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: EL3246, Location of injection: Arm Left, Vaccine Administration Time: 12:00 PM), administration date: 09Jan2021, when the patient was 75-year-old, for Covid-19 Immunization. The following information was reported: ISCHAEMIC STROKE (hospitalization, medically significant) with onset 04Apr2022 at 18:30, outcome "recovering", described as "I suffered 2 small ischemic strokes"; ATRIAL FIBRILLATION (hospitalization, medically significant) with onset 04Apr2022 at 18:30, outcome "recovering"; THROMBOSIS (hospitalization, medically significant) with onset 04Apr2022 at 18:30, outcome "recovering", described as "blood clots". The patient was hospitalized for atrial fibrillation, ischaemic stroke, thrombosis (hospitalization duration: 4 day(s)). The events "atrial fibrillation", "i suffered 2 small ischemic strokes" and "blood clots" required emergency room visit. Therapeutic measures were taken as a result of atrial fibrillation, ischaemic stroke, thrombosis. No follow-up attempts are possible. No further information is expected.
Arm pain and headache shortly after the injection. 5 hours after injection, visible injection site muscle twitching. 12 hours after injection swollen and painful left axcilla lymph nodes with all over body aches especially back and thumbs. 16 hours nausea, wretching, and later vomiting. Dehydration due to vomiting but had inappropriate diuresis. Had to urinate large amounts every 1 to 2 hours. Horrid chills with temp up to 102.9. Abnormal heartbeats. Not irregular or fast just abnormal.
pt recv vax 19MAR98 & 30MAR98 pt presented lupus-like sx w/erythema, painful joints, pruritus;devel swelling of the hands & feet;also exp impairment of grip w/morning stiffness;
no adverse event; a dose of VARIVAX was administered to the patient on 10AUG2022 after experiencing a temperautre excursion; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 10-AUG-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 milliliter, lot #U026207, expiration date: 24-AUG-2023 (strength, dosage regimen, anatomical location, and route of administration were not provided) as prophylaxis. It was reported that the vaccine underwent a temperature excursion of 18.6 Fahrenheit degrees for 30 minutes, with a previous temperature excursion of 9.8 Fahrenheit degrees for 30 minutes (product storage error). No adverse event was reported.  This is one of several cases reported by the same reporter.
Sweaty, anxious, increased HR 92-100, mild tremors, nauseated.
SORE THROAT, CHEST PRESSURE,  RHINORRHEA AND NASAL CONGESTION  Narrative:
little bit of reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (little bit of reaction) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (little bit of reaction). At the time of the report, VACCINATION COMPLICATION (little bit of reaction) outcome was unknown.            No concomitant medications was reported. No treatment drug details was reported.   This case was linked to MOD-2021-377770 (Patient Link).
Pt. received Influenza vaccine then 15 min after developed 1"x1" hive at injection site. Pt was given BENADRYL and became tachypnic, pale, c/o mouth feeling funny, central cyanosis. Pt. received Epinephrine, 911 called , and O2. Pt. then vomited. Pt. left office on O2, talking, alert and awake.
no adverse outcome.  Pt had already received full hep B series, but needed to start Hep A.  Given Twinrix instead of just Hep A.
pt recv vax & devel severe local rxn (redness, puffiness, warm to touch, etc) of long duration; one case devel into cellulitis; it is believed that all doses were fr the same lot
rash immed p/vax seemed to go away then appear in a different area;sinus h/a, body aches, & tight chest appeared 2 days p/vax;feels ill & feverish 6 days p/vax;
Pt call on 10/16/08 at 9:15 AM and complain of having chills, fever, swelling, hardness, small bumps with itching to the left arm at the site of the Varicella immunization given 10/14/2008. Pt verbalized the symptoms started 10/15/2008 at approximately 2:00 pm. Nurse told pt to go to nearest Emergency Room. Pt went to hospital and was given prescription for KEFLEX 500mg and ATARAX 25mg and told to follow up with PCP within 2-4 days if symptoms increase.
Patient received vaccine 5-8-09; noticed erythema, tenderness and warmth 5-9-09 (10x10 cm area at injection site). Doctor visit 5-11-09. Prescription for KEFLEX 500 mg 3x day x 7 days.
Pigmentation changes (redness, pain, warm to touch), diagnosed as cellulitis, rx'd cephalexin course.
In order of occurrence:  Runny nose Sore arm Congestion  Chills, aches, and fever like symptoms  Slight dizziness  Congestion cough
Day after vaccine administration pt. reported spitting up phlegm, dizziness, cramping (abdomen), trouble breathing, increase in blood pressure. Patient was admitted to ER and discharged two days later.
pain at injection site; swelling at injection site; sore left arm; sore elbow joints (both arms); This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8733) via an unspecified route of administration in the left arm on 25Mar2021 at 13:30 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Medical history included persistent atrial fibrillation. The patient had no known allergies. Concomitant medications included acetylsalicylic acid (ASPRIN 18 mg) from unknown date for unknown indication. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EN6204) via an unspecified route of administration in the left arm on 04Mar2021 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did received other vaccines within four weeks prior to the vaccination. On 26Mar2021 the patient experienced pain at vaccination site, swelling at vaccination site, sore left arm and sore elbow joints (both arms). The adverse events had not resulted in a visit to the doctors or other healthcare professional office or clinic visit or emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events pain at vaccination site, swelling at vaccination site, sore left arm and sore elbow joints was recovered on unknown date.  No follow-up attempts are needed. No further information is expected.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2014, the patient was inoculated with ZOSTAVAX as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. In 2015, the patient was treated by a physician for the onset of a vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related.
Patient received second influenza vaccine this season. First dose: 10/3/2022. Second dose 10/6/2022. No adverse reaction after immunizations given. Parent advised to monitor for increased soreness, fever or other adverse reaction.
PATIENT RECIEVES 1ST MODERNA COVID VACCINE. FIVE MINUTES POST VACCINATION PATIENT STARTED TO FEEL DIZZY, FAINTS AND HITS HEAD.  911 IS CALLED BY A BYSTANDER. PATIENT BECOMES ORIENTED AND STATES HE IS FINE. PATIENT IS TAKEN INTO CARE OF PARAMEDIC TEAM.
pt recv vax 29SEP95 & 25OCT96 pt exp acute myelopathy w/upper limbs, paresthesia & hypoesthesia;pt hosp on 5NOV98;spinal fluid nl but angiotensin II converting level was inc;dx sarcoidosis;APR97 paresthesia as well as opthalmoplegia;
Per mom Hep A given to (L) thigh on 3/6/12 and swelling at site greater than 4 quarter. Mom applied ice, and by day 3 (today) sx improved to swelling size of 2 quarters. No fever or other sx.
Heart Attack Pain short but very strong with pain..  Moderna..    I got a Pfizer Booster and the next morning had pressure and pain.  Chewed 3-325mg aspirin and sat still for 2 hours to let it subside.  I haven't been able to get an appointment with a Cardiologist.  I have been trying.
Head ache for 2 days and severe trigeminal face pain. Like a severe one day cold also. Took Carbamezapine and went to bed. If it would have lasted more than one day would have went to hospital. A terrible experience.  I have trigeminal neuralgia so I think the shot intensified the pain tremendously.
Pain in all joints, aches in arm muscle and legs, headache, neck pain, chills, depression, tingling and burning in arms and legs, confusion.
This spontaneous report as received from a registered nurse refers to a 12 months old female patient. On 21-DEC-2012 the patient was inadvertently vaccinated with a 0.5 ml dose of (Merck) PROQUAD (Lot# reported as 0689AE, expired on 05-MAY-2014) subcutaneously and a dose of (Merck) VARIVAX (Lot# reported as H015631, expired on 23-FEB-2014, dose and route not reported). It was staff error only. Both vaccines were administered in the patient's left thigh. No adverse effects were reported as this time. It was not known if the patient sought medical attention. Additional information is not expected.
Pain and swelling at injection site, fever, chills, muscle and joint aches, dizziness, weakness, fatigue
Child was not seen in our facility, seen by school APRN. She reports child had local reaction on her right arm with redness and swelling. Benadryl was given.
Hives noted 7mm took Benadryl none in am, so not seen in office.
The patient experienced an unknown taste after receiving Moderna as well as dizziness and fainting. She also had periods of feeling faint. The store management was called and alerted EMS which arrived after 20 minutes approximately. Basic vitals were taken and the patient was taken to the hospital.
Eye spasms/eye twitching; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a non-health professional and describes the occurrence of BLEPHAROSPASM (Eye spasms/eye twitching) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BLEPHAROSPASM (Eye spasms/eye twitching). At the time of the report, BLEPHAROSPASM (Eye spasms/eye twitching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
This spontaneous case initially received from other non-health professional (consumer) on 17-Oct-2018, concerning a adult female patient of an unspecified age. On 09-Oct-2018, the patient was administered FLUCELVAX QIV (dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number and expiry date: not reported). On the same day, the patient experienced low fever, headache, pain and sore in the muscles and lot of trouble in sleeping during night. The patient administered painkillers (medication unspecified) as the treatment medication as the patient still had fever. At the time of report, the patient had not recovered from the event fever and the outcome of the events headache, muscle pain and insomnia were not reported. The reporter assessed this case as non-serious.
The patient began having body pain, diaphoresis, dyspnea, abdominal pain, and fatigue approx 14d post-COVID vaccine (2nd dose, Pfizer). He presented to our hospital on 6/18 with these complaints and was found to have significantly altered mentation, acute kidney injury, and profound thrombocytopenia. Workup was positive for TTP and he was started on PLEX therapy x 5d. Hematologic parameters, renal function, and mentation have improved with PLEX therapy. ADAMTS-13 activity <5% c/w acquired TTP.
Pharyngitis; Hard area on the injection site; injection site redness; injection site swelling; injection site itching; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGITIS, VACCINATION SITE INDURATION, VACCINATION SITE ERYTHEMA, VACCINATION SITE SWELLING, and VACCINATION SITE PRURITUS in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Influenza, Influenza vaccine in 2020; for Pneumonia, PNEUMOCOCCAL VACCINE in November 2020. Past adverse reactions to the above products included No adverse reaction with Influenza vaccine and PNEUMOCOCCAL VACCINE. Concurrent medical conditions included Asthma.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PHARYNGITIS, VACCINATION SITE INDURATION, VACCINATION SITE ERYTHEMA, VACCINATION SITE SWELLING, and VACCINATION SITE PRURITUS. The patient was treated with ACETYLSALICYLIC ACID at an unspecified dose and frequency; BENADRYL at an unspecified dose and frequency and HYDROCORTISONE at an unspecified dose and frequency. At the time of the report, PHARYNGITIS, VACCINATION SITE INDURATION, VACCINATION SITE ERYTHEMA, VACCINATION SITE SWELLING, and VACCINATION SITE PRURITUS had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Updated medically confirm  from NO to YES. updated patient medical history, Re-challenge fields, added new event Pharyngitis, updated outcome of the events Vaccination site erythema, vaccination site swelling, vaccination site pruritus, vaccination site induration from unknown to Recovered. Patient declined to provide additional information.
Received shot at 3:30  PM by 9:00 PM my arm was hurting difficult to lift. I started feeling achey all over joint and muscle pain. At 12:00am fever of 100.1. Took 2 advil.  Awoke at 5:30 a.m and hurt all over, chills and fever of 100.0.
Patient is fully vaccinated and boosted.  COVID + at ED visit on 2/5/2022. 24-year-old female presents to the ED complaining of chest pain.  Patient states that she has been experiencing intermittent substernal chest pain for the past 2 days.  She does admit to intermittent associated shortness of breath. Positive for fatigue, myalgias, arthralgias. Tachycardia present. No CT evidence for central or segmental Pulmonary Embolism. Troponin normal. EKG: Normal sinus rhythm. Cannot rule out Anterior infarct. Iopamidol given, zofran and fluid.  Discharged home.
COVID shots Shot Feb 1, 2021 Day one of shot fatigue Day two of shot thigh cramps Day three of shot nausea  Day four of shot back and joint pain Day five of shot sick feeling aching all over. Muscle and joint pain and fatigue. Chest pressure, cough, Hoarse voice Day six of shot headache fatigue pain through right eye.  2/5Temp 96.6, 98.6, 1:00pm  SPO% 93%   Resting heart rate 90  6:30pm SPO% 89%-91%  Resting heart rate 102  Tylenol 100 mg 9:00am, 3:30pm TEMP 4:30pm 99.7*   Symptoms of the freezing chest and cough as well as headache and feeling poorly kept rising several times a week.  Covid 3/1/21 Covid symptoms return just like after Covid 19 1st vaccine. Body aches, joint pain, Chest pain, muscle aches, frozen feeling in lungs, cough, abdominal pain,eye ache, headache and fever. Temp 95.5 SPO 89% - 94% Resting heart rate 92 - 95 (After Covid shot 89%SPO, RHR 105, temp 99.7)  12:25pm temp 99  2/2/21 Feeling a little better. Still fatigue and ill feelings. At nighttime cough comes back with freezing lung feeling. Also started and body aches and joint stiffness. Went to bed took ibuprofen.  2/3/21 Still feeling ill . Woke with productive cough a little looser. Headache fatigue just feeling crummy.
Pt presented with large red area surrounding injection site. Varicella vaccine given 9/1/2009 in (L) deltoid. No fever. Other vitals stable. Pt started on KEFLEX. Questionable cellulitis vs vaccine reaction.
Fever of 102.5F, cold chills, vomitting, muscle and joint pain. Slept and hydrated to relieve symptoms.
Last week, five weeks after the COVID booster, I had sudden onset of severe migraines with cognitive and speech difficulty and visual disturbances. The same thing had happened five weeks after my 2nd COVID vaccine, although not as severe. The previous migraines came every day for 2 weeks and then less often, stopping after about 3 months. This time I have had them constantly for a week. They are getting less severe and no longer affecting my speech. I hope they too will go away within 3 months. The reason I am reporting this now is that the timing of the previous two shots and the migraines is suspicious.
This spontaneous report was received from a medical assistant and a nurse and refers to a 23-year-old female patient with no concomitant therapies. It was reported that the patient visited made some contraceptive consultation visits and in November 2016, she visited her provider due to an abdominal pain. Other medical history included headaches. There was no information about the patient's drug reactions or allergies. On 23-MAR-2017, the patient was vaccinated with an expired second dose of VARIVAX 0.5 mL, lot number: L008269, expiration date: 11-MAR-2017 (strength, route of administration, and anatomical location were not provided) as routine vaccination. Other suspect therapies included sterile diluent(STERILE VARIVAX DILUENT) (lot number and expiration date unknown). It was reported by the medical assistant that on the same date, the patient experienced a "normal soreness at injection site" (injection site pain); however, it was reported by the nurse that the patient did not have an adverse reaction. No laboratory tests or diagnostic procedures were performed to the patient. On 27-MAR-2017, reported as "today", the patient was following up in the clinic. At the time of reporting, it was unknown whether the patient recovered or not from the event of injection site pain. There was no product quality complaint involved. The causal relationship between the therapy with VARIVAX and the event of injection site pain was not reported. Additional information has been requested.
following DTP vax, area became hot & infected, the size of a quarter p/8 days; sterile abscess was dx by MD;
Pt noticed erythema ~2 1/2 inches oval with warmth about 24 hrs after imm. 48 hrs-72 hrs later the redness increased to 17 x 13 cm oval on (R) upper arm area with central oval 4 x 4 cm nodule, tender pink, slightly raised , warm.